[PERSON]
Wegovy
Featured in 2 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
315 clusters · 1160 sources · last updated
Latest: GLP-1 weight loss drugs drive surge in protein-based products
The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, and neurodegenerative health. A large-scale U.S. study sug
Novo Nordisk pivots strategy to counter patent cliff
112 clusters · 548 sources · last updated
Latest: Novo Nordisk faces intense competition in obesity drug market
Novo Nordisk is implementing a strategic reset to address long-term growth concerns and the looming patent expiration of semaglutide in the early 2030s. To diversify its portfolio and counter competition from Eli Lilly,